232 related articles for article (PubMed ID: 37434681)
21. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
[TBL] [Abstract][Full Text] [Related]
22. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
23. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586
[TBL] [Abstract][Full Text] [Related]
24. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract][Full Text] [Related]
25. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
26. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
He T; Xia H; Chen B; Duan Z; Huang C
Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
[TBL] [Abstract][Full Text] [Related]
27. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
28. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.
Tang Y; Gao G; Xia WW; Wang JB
Cell Signal; 2022 Nov; 99():110440. PubMed ID: 35985439
[TBL] [Abstract][Full Text] [Related]
29. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
30. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
[TBL] [Abstract][Full Text] [Related]
31. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
Chang X; Lin YY; Bai LN; Zhu W
J Chemother; 2022 Feb; 34(1):55-66. PubMed ID: 34286671
[TBL] [Abstract][Full Text] [Related]
32. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
[TBL] [Abstract][Full Text] [Related]
33. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
[TBL] [Abstract][Full Text] [Related]
34. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3.
Wu J; Wang W; Zheng Y; Deng W; Liu J
Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599
[TBL] [Abstract][Full Text] [Related]
36. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
Dong G; Yu J; Shan G; Su L; Yu N; Yang S
Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
[TBL] [Abstract][Full Text] [Related]
37. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
38. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
He G; Gu K; Wei J; Zhang J
Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740
[TBL] [Abstract][Full Text] [Related]
39. METTL3 mediates SOX5 m6A methylation in bronchial epithelial cells to attenuate Th2 cell differentiation in T2 asthma.
Chen Z; Shang Y; Zhang X; Duan W; Li J; Zhu L; Ma L; Xiang X; Jia J; Ji X; Gong S
Heliyon; 2024 Apr; 10(7):e28884. PubMed ID: 38601672
[TBL] [Abstract][Full Text] [Related]
40. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.
Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z
Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]